Mobile app version of munafa.co.com
Login or Join
 Learn then Earn
stockMarketNEWS

 story : FDA says COVID-19 boosters should be updated to combat two omicron subvariants #FinanceUSA #StockMarketNEWS The Food and Drug Administration on Thursday told COVID-19 vaccine makers that plan to update

@stockMarketNEWS Fri 01 Jul, 2022

Posted in: #FinanceUSA #StockMarketNEWS

FDA says COVID-19 boosters should be updated to combat two omicron subvariants #FinanceUSA #StockMarketNEWS
The Food and Drug Administration on Thursday told COVID-19 vaccine makers that plan to update their boosters to add a BA.4 and BA.5 spike protein component to the new shots that are in development. These "bivalent" boosters should equally target the two subvariants of omicron as well as the original strain of the virus and are expected to be rolled out to Americans in the fall or winter. Earlier this week, the FDA's advisory committee on vaccines voted 19-2 that the COVID-19 boosters need to be modified to better combat omicron and its subvariants. The BA.4 and BA.5 subvariants now make up more than half of U.S. cases. The FDA said the primary series of shots will not be updated at this time. Moderna Inc., BioNTech SE and Pfizer Inc. , and Novavax Inc. said this week that they plan to modify their COVID-19 boosters. Johnson & Johnson has no plans to modify its COVID-19 shot.


Munafa USA Munafa India Munafa NSE


Report

Login to follow story

More posts by @stockMarketNEWS

Munafa ebook, learn stock market trading

0 Comments

Sorted by latest first Latest Oldest Best

Daily analysis, news, Munafa stocks list in email:

Back to top | Use Dark Theme